Bath & Body Works, Inc. (NYSE:BBWI) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Bath & Body Works, Inc. (NYSE:BBWI) have been given a consensus recommendation of “Moderate Buy” by the seventeen analysts that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating and ten have issued a buy rating on the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $43.06.

BBWI has been the topic of several research analyst reports. Piper Sandler raised their price target on shares of Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. Deutsche Bank Aktiengesellschaft lifted their target price on Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Morgan Stanley reduced their price objective on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research report on Thursday, November 21st. Argus reissued a “hold” rating on shares of Bath & Body Works in a report on Friday, January 10th. Finally, Telsey Advisory Group restated an “outperform” rating and issued a $42.00 target price on shares of Bath & Body Works in a research note on Monday, November 25th.

Bath & Body Works Stock Up 0.3 %

Shares of NYSE:BBWI opened at $36.78 on Monday. The company has a market cap of $7.97 billion, a price-to-earnings ratio of 8.97, a PEG ratio of 0.98 and a beta of 1.82. The business has a 50 day moving average price of $36.30 and a 200 day moving average price of $33.68. Bath & Body Works has a twelve month low of $26.20 and a twelve month high of $52.99.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The company had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.58 billion. During the same period in the prior year, the business earned $0.48 earnings per share. Bath & Body Works’s revenue for the quarter was up 3.1% compared to the same quarter last year. Analysts anticipate that Bath & Body Works will post 3.26 EPS for the current year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Friday, November 22nd were paid a dividend of $0.20 per share. The ex-dividend date was Friday, November 22nd. This represents a $0.80 annualized dividend and a yield of 2.18%. Bath & Body Works’s dividend payout ratio is 19.51%.

Institutional Investors Weigh In On Bath & Body Works

A number of hedge funds and other institutional investors have recently bought and sold shares of BBWI. Wellington Management Group LLP bought a new position in shares of Bath & Body Works in the third quarter worth about $8,129,000. Forest Avenue Capital Management LP raised its position in Bath & Body Works by 19.1% in the 3rd quarter. Forest Avenue Capital Management LP now owns 1,467,763 shares of the company’s stock worth $46,851,000 after purchasing an additional 235,173 shares during the last quarter. Anthracite Investment Company Inc. acquired a new position in Bath & Body Works during the 3rd quarter worth $2,921,000. Principal Financial Group Inc. boosted its position in Bath & Body Works by 328.7% in the 3rd quarter. Principal Financial Group Inc. now owns 1,069,941 shares of the company’s stock valued at $34,153,000 after buying an additional 820,379 shares during the last quarter. Finally, iA Global Asset Management Inc. boosted its position in Bath & Body Works by 1,078.2% in the 3rd quarter. iA Global Asset Management Inc. now owns 49,331 shares of the company’s stock valued at $1,575,000 after buying an additional 45,144 shares during the last quarter. 95.14% of the stock is owned by institutional investors and hedge funds.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.